)
Visual
test
Dr. Lal PathLabs
Dr. Lal PathLabs (LALPATHLAB) investor relations material
Dr. Lal PathLabs Q3 25/26 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Q3 25/26 earnings summary30 Jan, 2026
Executive summary
Achieved 10.6% year-on-year revenue growth in Q3 FY26 and 10.8% for the nine-month period, driven by organic growth, operational excellence, and network expansion in metro and Tier 3/4 cities.
Launched Sovaaka, a personalized preventive healthcare platform, and expanded high-end diagnostics in oncology, genomics, and infectious diseases.
SwasthFit preventive health packages contributed 26% to total revenue in 9M FY26, with growing adoption in smaller towns.
Unaudited consolidated and standalone financial results for the quarter and nine months ended December 31, 2025, were approved and reviewed without qualification by auditors.
Third interim dividend of INR 3.5 per equity share declared, with record date set for February 5, 2026, following a 1:1 bonus share issue.
Financial highlights
Q3 FY26 consolidated revenue: INR 6,598 million (Rs. 660 crore), up from INR 5,967 million (Rs. 597 crore) in Q3 FY25 (10.6% growth).
EBITDA before exceptional items: INR 1,790 million (Rs. 179 crore) in Q3 FY26 (27.2% margin), up 16.3% year-on-year.
Profit after tax for Q3 FY26: INR 914 million (Rs. 91 crore, PAT margin 13.9%), compared to INR 981 million (Rs. 98 crore) last year.
Earnings per share for Q3 FY26: INR 5.4, down from INR 5.8 in Q3 FY25; YTD EPS at INR 22.4.
Net cash and cash equivalents: INR 1,411 crore as of December 31, 2025.
Outlook and guidance
Management expects organic revenue growth to stabilize at 11%-12% for FY26, with potential for higher growth in future years.
EBITDA margin guidance maintained at 27%-28% for the full year, even after accounting for one-time Labour Code costs.
Focus on expanding network in underpenetrated markets, especially West and South India, and enhancing high-end test portfolio.
Continued investment in digital platforms, technology upgrades, and preventive wellness programs to drive future growth.
No price increases expected in the next 2-3 quarters following recent GST-related price cuts.
Future impact of Labour Codes on liabilities?
Risk from unaudited subsidiary financials?
Strategic rationale for SDIPL liquidation?
Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.
Latest summaries
- TimeTickerHeadlineOpen
- 7 Feb514167
Quarterly and nine-month results reflect solid revenue, profit, and compliance with new labour codes. - 7 FebMGL
Strong revenue growth offset by lower margins and profit; interim dividend declared. - 7 FebPGIL
Strong revenue and margin growth, with India set for further expansion and upgraded ratings. - 7 Feb504614
Strong revenue and profit growth in Q3 FY26, led by power and steel segments. - 7 FebCHEMPLASTS
Net losses widened and revenue fell year-over-year amid regulatory and market headwinds. - 7 FebSBIN
Q3 FY26 net profit reached ₹21,028.15 crore, driven by robust income and strategic divestments. - 6 FebHTOO
Resale registration for 71,429 shares via warrant, with proceeds only on exercise; financial risks persist. - 6 FebVSAT
Q3 revenue up 3% to $1.16B, net income $25M, strong cash flow, Ligado boost, satellite focus. - 6 FebWEC
Targets 7–8% EPS growth, $37.5B capex, and coal exit by 2032 amid surging data center demand. - 6 FebBR
Q2 FY26 recurring revenue grew 8% and adjusted EPS guidance was raised to 9-12%.
Next Dr. Lal PathLabs earnings date
Q4 202624 Apr, 2026
Dr. Lal PathLabs
Next Dr. Lal PathLabs earnings date
Q4 202624 Apr, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
Dr. Lal PathLabs Limited is an Indian diagnostics and healthcare service provider specializing in pathology and radiology testing services. The company offers a wide range of diagnostic tests, including blood tests, imaging, and specialized health screenings, catering to individual patients, hospitals, and other healthcare institutions. Dr. Lal PathLabs operates an extensive network of diagnostic centers and collection points across India, supported by centralized laboratories and advanced testing technology to ensure accuracy and quick turnaround. The company is headquartered in Gurugram, India, and its shares are listed on the NSE and BSE.
Quartr provides global coverage of all investor relation material from public companies.
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Yes, the Quartr mobile app is free on both iOS and Android.
Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.
Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.
Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.
Explore our global coverage